HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR "Evolution" Propelled By Industry Demand For More Ingredient Reviews

This article was originally published in The Rose Sheet

Executive Summary

Recent changes in the Cosmetic Ingredient Review Expert Panel's approach to ingredient evaluation have enabled the group to review more substances at its quarterly meetings

You may also be interested in...



CIR’s Draft Ingredient List For 2015 Review Raises No Red Flags

The CIR Expert Panel released its draft list of 22 cosmetic ingredients/ingredient groups targeted for review in 2015, all low-hazard substances according to the Environmental Working Group’s Skin Deep website. CIR introduced the draft roster ahead of schedule to allow more time for public input, and will issue a final priority list in June.

CIR Expert Panel Nears Ingredient Review Milestone

The Cosmetic Ingredient Review Expert Panel has reviewed the safety of nearly half of all ingredients in use in cosmetic products, CIR Director Alan Andersen said during the group’s December meeting.

CIR Releases 2013 Draft Review Priorities For Public Comment

The Cosmetic Ingredient Review maintains its current safety assessment approach, selecting ingredients with the highest reported uses for its 2013 draft priority list. The list is open for public comment, and will be finalized at the CIR Expert Panel’s September meeting.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel